I’ve been spotty recently with my calls. My attempts to call an end to the rally have been premature and off. However, I have been right on with three recent low priced recommendations, and now have another. The Chart says to Buy AGE, here under .90. After the big surge on an announcement of partnering with another company on a specific cell therapy for diabetes treatment, AGE has pulled back to major support and is a long term value at this level. BUY. Chartsmaster